Stemulite News: Metabolic Research, Inc. Announces Acquisition of Multiple Technologies

Tuesday, 15 May 2007 08:00pm EDT

Metabolic Research, Inc. announced that it has acquired the principal assets relating to metabolically engineered drug development, formulas, prototypes, packaging design and marketing rights from Partners in Science Holdings, Inc. The acquisition was completed through an all stock transaction utilizing restricted common shares of the Company. Included in the purchase are 15 product formulations, branding for four trademarks/trade names, six provisional patent applications, two technologies ready for patent filing, three contract executives, and one marketing contract.

SOURCE: Metabolic Research, Inc.